143 related articles for article (PubMed ID: 22058217)
1. CD20 expression has no prognostic role in Philadelphia-negative B-precursor acute lymphoblastic leukemia: new insights from the molecular study of minimal residual disease.
Mannelli F; Gianfaldoni G; Intermesoli T; Cattaneo C; Borlenghi E; Cortelazzo S; Cavattoni I; Pogliani EM; Fumagalli M; Angelucci E; Romani C; Ciceri F; Corti C; Scattolin A; Cortelezzi A; Mattei D; Audisio E; Spinelli O; Oldani E; Bosi A; Rambaldi A; Bassan R
Haematologica; 2012 Apr; 97(4):568-71. PubMed ID: 22058217
[TBL] [Abstract][Full Text] [Related]
2. Adverse prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia.
Maury S; Huguet F; Leguay T; Lacombe F; Maynadié M; Girard S; de Labarthe A; Kuhlein E; Raffoux E; Thomas X; Chevallier P; Buzyn A; Delannoy A; Chalandon Y; Vernant JP; Rousselot P; Macintyre E; Ifrah N; Dombret H; Béné MC;
Haematologica; 2010 Feb; 95(2):324-8. PubMed ID: 19773266
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of CD20 Expression in Children with Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia.
Wang Y; Xue YJ; Jia YP; Zuo YX; Lu AD; Zhang LP
Acta Haematol; 2023; 146(5):349-357. PubMed ID: 37212472
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemia.
Thomas DA; O'Brien S; Jorgensen JL; Cortes J; Faderl S; Garcia-Manero G; Verstovsek S; Koller C; Pierce S; Huh Y; Wierda W; Keating MJ; Kantarjian HM
Blood; 2009 Jun; 113(25):6330-7. PubMed ID: 18703706
[TBL] [Abstract][Full Text] [Related]
5. Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis.
Herold T; Schneider S; Metzeler KH; Neumann M; Hartmann L; Roberts KG; Konstandin NP; Greif PA; Bräundl K; Ksienzyk B; Huk N; Schneider I; Zellmeier E; Jurinovic V; Mansmann U; Hiddemann W; Mullighan CG; Bohlander SK; Spiekermann K; Hoelzer D; Brüggemann M; Baldus CD; Dreyling M; Gökbuget N
Haematologica; 2017 Jan; 102(1):130-138. PubMed ID: 27561722
[TBL] [Abstract][Full Text] [Related]
6. International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia.
Gökbuget N; Dombret H; Ribera JM; Fielding AK; Advani A; Bassan R; Chia V; Doubek M; Giebel S; Hoelzer D; Ifrah N; Katz A; Kelsh M; Martinelli G; Morgades M; O'Brien S; Rowe JM; Stieglmaier J; Wadleigh M; Kantarjian H
Haematologica; 2016 Dec; 101(12):1524-1533. PubMed ID: 27587380
[TBL] [Abstract][Full Text] [Related]
7. Achieving Molecular Remission before Allogeneic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Impact on Relapse and Long-Term Outcome.
Lussana F; Intermesoli T; Gianni F; Boschini C; Masciulli A; Spinelli O; Oldani E; Tosi M; Grassi A; Parolini M; Audisio E; Cattaneo C; Raimondi R; Angelucci E; Cavattoni IM; Scattolin AM; Cortelezzi A; Mannelli F; Ciceri F; Mattei D; Borlenghi E; Terruzzi E; Romani C; Bassan R; Rambaldi A
Biol Blood Marrow Transplant; 2016 Nov; 22(11):1983-1987. PubMed ID: 27492792
[TBL] [Abstract][Full Text] [Related]
8. A systematic literature review and meta-analysis of minimal residual disease as a prognostic indicator in adult B-cell acute lymphoblastic leukemia.
Bassan R; Brüggemann M; Radcliffe HS; Hartfield E; Kreuzbauer G; Wetten S
Haematologica; 2019 Oct; 104(10):2028-2039. PubMed ID: 30890593
[TBL] [Abstract][Full Text] [Related]
9. Management of patients with acute lymphoblastic leukemia in routine clinical practice: Minimal residual disease testing, treatment patterns and clinical outcomes in Belgium, Greece and Switzerland.
Deeren D; Balabanov S; Nickel K; Giannopoulou C; Gonzalez-McQuire S; Kutikova L; Bouwmeester W; Spyridonidis A
Leuk Res; 2020 Apr; 91():106334. PubMed ID: 32135394
[TBL] [Abstract][Full Text] [Related]
10. [Minimal residual disease in adults with Philadelphia chromosome negative acute lymphoblastic leukemia in high-risk].
Li ZR; Zhao T; Liu YR; Wang YZ; Xu LP; Zhang XH; Wang Y; Jiang H; Chen YY; Chen H; Han W; Yan CH; Wang J; Jia JS; Huang XJ; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2019 Jul; 40(7):554-560. PubMed ID: 32397017
[No Abstract] [Full Text] [Related]
11. Superior survival of unmanipulated haploidentical haematopoietic stem cell transplantation compared with intensive chemotherapy as post-remission treatment for children with very high-risk philadelphia chromosome negative B-cell acute lymphoblastic leukaemia in first complete remission.
Xue YJ; Suo P; Huang XJ; Lu AD; Wang Y; Zuo YX; Yan CH; Wu J; Kong J; Zhang XH; Chen YH; Jia YP; Liu KY; Han W; Xu LP; Zhang LP; Cheng YF
Br J Haematol; 2020 Mar; 188(5):757-767. PubMed ID: 31725190
[TBL] [Abstract][Full Text] [Related]
12. The early achievement of measurable residual disease negativity in the treatment of adults with Philadelphia-negative B-cell acute lymphoblastic leukemia is a strong predictor for survival.
Yilmaz M; Kantarjian H; Wang X; Khoury JD; Ravandi F; Jorgensen J; Short NJ; Loghavi S; Cortes J; Garcia-Manero G; Kadia T; Sasaki K; Konopleva M; Takahashi K; Wierda W; Jain N; Verstovsek S; Estrov Z; Bose P; Pierce S; Garris R; O'Brien S; Jabbour E
Am J Hematol; 2020 Feb; 95(2):144-150. PubMed ID: 31682008
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Effect of CD20 Expression in Adult B-cell Acute Lymphoblastic Leukemia.
Esteban RE; Christianne B; Alvaro A; Demichelis-Gómez R
Clin Lymphoma Myeloma Leuk; 2018 May; 18(5):361-367. PubMed ID: 29544762
[TBL] [Abstract][Full Text] [Related]
14. CD20 expression in B-cell precursor acute lymphoblastic leukemia is common in Mexican patients and lacks a prognostic value.
Solano-Genesta M; Tarín-Arzaga L; Velasco-Ruiz I; Lutz-Presno JA; González-Llano O; Mancías-Guerra C; Rodríguez-Romo L; Ruiz-Delgado GJ; Ruiz-Argüelles GJ; Jaime-Pérez JC; Gómez-Almaguer D
Hematology; 2012 Mar; 17(2):66-70. PubMed ID: 22664043
[TBL] [Abstract][Full Text] [Related]
15. Clinicians' Perspectives on Cure in Adult Patients with Acute Lymphoblastic Leukemia with Minimal Residual Disease: A Delphi Study.
Gidman W; Shah S; Zhang L; McKendrick J; Cong Z; Cohan D; Ottmann O
Adv Ther; 2019 Nov; 36(11):3017-3029. PubMed ID: 31586302
[TBL] [Abstract][Full Text] [Related]
16. CD20 has no prognostic significance in children with precursor B-cell acute lymphoblastic leukemia.
Naithani R; Asim M; Abdelhaleem M; Punnett A
Haematologica; 2012 Sep; 97(9):e31-2. PubMed ID: 22952332
[No Abstract] [Full Text] [Related]
17. Outcome of CD20-positive Adult B-cell Acute Lymphoblastic Leukemia and the Impact of Rituximab Therapy.
Alduailej H; Kanfar S; Bakhit K; Raslan H; Alsaber A; Bashawri L; Aldayel A; Alanezi K
Clin Lymphoma Myeloma Leuk; 2020 Sep; 20(9):e560-e568. PubMed ID: 32600932
[TBL] [Abstract][Full Text] [Related]
18. Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.
Xu N; Li YL; Li X; Zhou X; Cao R; Li H; Li L; Lu ZY; Huang JX; Fan ZP; Huang F; Zhou HS; Zhang S; Liu Z; Zhu HQ; Liu QF; Liu XL
J Hematol Oncol; 2016 Apr; 9():40. PubMed ID: 27090891
[TBL] [Abstract][Full Text] [Related]
19. Blinatumomab for the Treatment of Philadelphia Chromosome-Negative, Precursor B-cell Acute Lymphoblastic Leukemia.
Wolach O; Stone RM
Clin Cancer Res; 2015 Oct; 21(19):4262-9. PubMed ID: 26283683
[TBL] [Abstract][Full Text] [Related]
20. Relevance of CD20 antigen expression among paediatric patients with B-lineage acute lymphoblastic leukaemia.
Bommannan K; Arumugam JR; Radhakrishnan V; Sundersingh S
Br J Haematol; 2024 Apr; 204(4):1367-1374. PubMed ID: 38444113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
